We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Plexium

News List

Plexium Selects Xavo as Their Sample Management Lab Operations Platform Biotech Newswire
July 25, 2024
Xavo proudly announces Plexium as its latest esteemed client. The collaboration between the two companies marks a significant milestone in Xavo’s journey.
Favored by Capital and Hot Among Pharma Companies, This Small-molecule Degradation Agent Company Has Great Potential PharmaSources/Xiaobing
March 21, 2022
While many pharmaceutical companies are chasing targeted and immunotherapy therapeutic drugs, protein degradation therapy has also attracted the attention of more and more companies and has become another new direction in the field of new drug R&D.
Amgen and Plexium announce multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies WorldPharmaNews
February 07, 2022
Amgen (NASDAQ:AMGN) and Plexium, Inc. (Plexium) today announced an exclusive, worldwide, multi-year research collaboration and license agreement to identify novel targeted protein degradation therapeutics...